Abstract:Platelet donors sometimes show an increased platelet count following apheresis. We analyzed the effect of plasma obtained from such donors, along with thrombopoietin (Tpo), for growth and differentiation-inducing activity on a megakaryoblastic leukemia cell line, Meg-J. Colony formation was stimulated by donor plasma for Meg-J cells in a dose-dependent manner, and the time course of the sampling peaked 1 day after apheresis. Neither the donor plasma nor Tpo induced morphological differentiation. Donor plasma f… Show more
“…Administration of recombinant TPO has been shown to greatly increase the number of circulating CFU‐Mk in patients with cancer [7]. Plasma obtained from platelet donors 1 day after apheresis stimulated growth rather than induced differentiation of a megakaryoblastic cell line [8]. On the other hand, other thrombopoietic growth factors, such as IL‐6 and IL‐1β[1], remain unchanged following plateletpheresis.…”
These findings suggest that platelet loss during plateletpheresis affects thrombopoiesis at the progenitor cell level, probably through alterations in TPO plasma concentrations.
“…Administration of recombinant TPO has been shown to greatly increase the number of circulating CFU‐Mk in patients with cancer [7]. Plasma obtained from platelet donors 1 day after apheresis stimulated growth rather than induced differentiation of a megakaryoblastic cell line [8]. On the other hand, other thrombopoietic growth factors, such as IL‐6 and IL‐1β[1], remain unchanged following plateletpheresis.…”
These findings suggest that platelet loss during plateletpheresis affects thrombopoiesis at the progenitor cell level, probably through alterations in TPO plasma concentrations.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.